TBCE

Chr 1AR

tubulin folding cofactor E

Also known as: HRD, KCS, KCS1, PEAMO, pac2

Cofactor E is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.813 OMIM phenotypes
Clinical SummaryTBCE
🧬
Gene-Disease Validity (ClinGen)
encephalopathy, progressive, with amyotrophy and optic atrophy · ARModerate

Moderate evidence — consider for supplementary testing

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
84 unique Pathogenic / Likely Pathogenic· 193 VUS of 726 total submissions
📖
GeneReview available — TBCE
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.81LOEUF
pLI 0.000
Z-score 2.44
OE 0.54 (0.370.81)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.12Z-score
OE missense 0.98 (0.891.08)
276 obs / 281.7 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.54 (0.370.81)
00.351.4
Missense OE?0.98 (0.891.08)
00.61.4
Synonymous OE?1.05
01.21.6
LoF obs/exp: 18 / 33.2Missense obs/exp: 276 / 281.7Syn Z: -0.40
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveTBCE-related hypoparathyroidism-retardation-dysmorphism syndromeLOFAR
strongTBCE-related early-onset progressive encephalopathy with distal spinal muscular atrophyOTHERAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6938th %ile
GOF
0.5955th %ile
LOF
0.2679th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

726 submitted variants in ClinVar

Classification Summary

Pathogenic58
Likely Pathogenic26
VUS193
Likely Benign323
Benign77
Conflicting31
58
Pathogenic
26
Likely Pathogenic
193
VUS
323
Likely Benign
77
Benign
31
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
42
0
16
0
58
Likely Pathogenic
18
5
3
0
26
VUS
10
150
26
7
193
Likely Benign
1
14
158
150
323
Benign
1
2
70
4
77
Conflicting
31
Total72171273161708

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

51 pathogenic / likely-pathogenic (of 68) ClinVar copy-number / structural variants overlap TBCE — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TBCE · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →